1. (a) Negishi, E.i.; Huang, Z.; Wang, G.; Mohan, S.; Wang, C.; Hattori, H. “Recent Advances in Efficient and Selective Synthesis of Di- Tri- and Tetrasubstituted Alkenes via Pd- Catalyzed Alkenylation–Carbonyl Olefination Synergy”. Accounts of Chemical Research 41 (2008): 1474. (b) Oger, C.; Balas, L.; Durand, T.; Galano, J. M. “Are alkyne reductions chemo- regio- and stereoselective enough to provide pure (Z)-olefins in polyfunctionalized bioactive molecules?” Chemical Reviews 113 (2013): 1313. (c) Mailig, M.; Hazra, A.; Armstrong, M. K.; Lalic, G. “Catalytic Anti-Markovnikov Hydroallylation of Terminal and Functionalized Internal Alkynes: Synthesis of Skipped Dienes and Trisubstituted Alkenes”. Journal of the American Chemical Society 139 (2017): 6969. (d) Han, H. S.; Lee, Y. J.; Jung, Y. S.; Han, S. B. “Stereoselective Photoredox-Catalyzed Chlorotrifluoromethylation of Alkynes: Synthesis of Tetrasubstituted Alkenes”. Organic Letters 19 (2017): 1962. (e) Manikandan, R.; Jeganmohan, M. “Recent advances in the ruthenium(II)-catalyzed chelation-assisted C–H olefination of substituted aromatics, alkenes and heteroaromatics with alkenes via the deprotonation pathway”. Chemical Communications 53 (2017): 8931. (f) Kumar, R.; Dwivedi, V.; Reddy, M. S. “Metal- Free Iodosulfonylation of Internal Alkynes: Stereodefined Access to Tetrasubstituted Olefins”. Advanced Synthesis & Catalysis 359 (2017): 2847.
2. (a) Robertson, D. W.; Katzenellenbogen, J. A.; Hayes, J. R.; Katzenellenbogen, B. S. “Antiestrogen basicity–activity relationships: a comparison of the estrogen receptor binding and antiuterotrophic potencies of several analogues of (Z)-1,2-diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-butene (tamoxifen, Nolvadex) having altered basicity”. Journal of Medicinal Chemistry 25 (1982): 167. (b) Wu, P.; Wang, L.; Wu, K.; Yu, Z. “Total Synthesis of Kopsinine ”. Organic Letters 17 (2015): 868. (c) Higman, C. S.; Lummiss, J. A. M.; Fogg, D. E. “Olefin Metathesis at the Dawn of Implementation in Pharmaceutical and Specialty- Chemicals Manufacturing”. Angewandte Chemie (International ed. in English) 55 (2016): 3552.
3. (a) Levenson, A. S.; Jordan, V. C. “Selective oestrogen receptor modulation: molecular pharmacology for the millennium”. European Journal of Cancer 35 (1999): 1628. (b) Gigant, N.; Quintin, F.; Bäckvall, J. E. “Preparation of tetrasubstituted olefins using mono or double aerobic direct C-H functionalization strategies: importance of steric effects”. The Journal of Organic Chemistry 80 (2015): 2796. (c) Lim, N.K.; Weiss, P.; Li, B. X.; McCulley, C. H.; Hare, S. R.; Bensema, B. L.; Palazzo, T. A.; Tantillo, D. J.; Zhang, H.M.; Gosselin, F. “Synthesis of Highly Stereodefined Tetrasubstituted Acyclic All-carbon Olefins via a syn-Elimination Approach”. Organic Letters 19 (2017): 6212.
4. Bhatt, S.; Stender, J. D.; Joshi, S.; Wu, G.; Katzenellenbogen, B. S. “OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells”. Oncogene 35 (2016): 5722. (c) Kortman, G. D.; Hull, K. L. “Copper-Catalyzed Hydroarylation of Internal Alkynes: Highly Regio- and Diastereoselective Synthesis of 1,1-Diaryl, Trisubstituted Olefins”. ACS Catalysis 7 (2017): 6220.